ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
-8.08%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$620M
AUM Growth
+$620M
(-26%)
Cap. Flow
-$114M
Cap. Flow
% of AUM
-18.41%
Top 10 Holdings %
Top 10 Hldgs %
63.09%
Holding
38
New
9
Increased
7
Reduced
7
Closed
13
Top Buys
| 1 |
Humana
HUM
|
$46.8M |
| 2 |
Repligen
RGEN
|
$40.6M |
| 3 |
Boston Scientific
BSX
|
$37.3M |
| 4 |
Neurocrine Biosciences
NBIX
|
$34.1M |
| 5 |
DexCom
DXCM
|
$32M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$45.9M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
$43.5M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$40.7M |
| 4 |
Illumina
ILMN
|
$38.4M |
| 5 |
Hologic
HOLX
|
$36.9M |
Sector Composition
| 1 | Healthcare | 98.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AbbVie
ABBV
$372B
| $53.6M | 6.95% | 350,000 +110,000 | +46% | +$16.8M |
|
|
2
Humana
HUM
$36.5B
| $46.8M | 6.07% | +100,000 | New | +$46.8M |
|
|
3
Repligen
RGEN
$6.88B
| $40.6M | 5.26% | +250,000 | New | +$40.6M |
|
4
Guardant Health
GH
$8.41B
| $40M | 5.18% | 990,568 +268,442 | +37% | +$10.8M |
|
|
5
Boston Scientific
BSX
$156B
| $37.3M | 4.83% | +1,000,000 | New | +$37.3M |
|
|
6
DexCom
DXCM
$29.5B
| $37.3M | 4.83% | 500,000 +430,000 | +614% | +$32M |
|
7
Acadia Healthcare
ACHC
$2.12B
| $37.2M | 4.82% | 550,000 +47,360 | +9% | +$3.2M |
|
8
Icon
ICLR
$13.8B
| $34.7M | 4.5% | 160,000 -107,551 | -40% | -$23.3M |
|
|
9
Neurocrine Biosciences
NBIX
$13.8B
| $34.1M | 4.42% | +350,000 | New | +$34.1M |
|
10
HealthEquity
HQY
$7.72B
| $29.8M | 3.87% | 485,541 -1,321 | -0.3% | -$81.1K |
|
11
AstraZeneca
AZN
$248B
| $28.9M | 3.75% | 437,477 +57,477 | +15% | +$3.8M |
|
12
Bio-Rad Laboratories Class A
BIO
$8.06B
| $28.7M | 3.72% | +57,955 | New | +$28.7M |
|
13
Legend Biotech
LEGN
$6.41B
| $27.2M | 3.53% | +495,329 | New | +$27.2M |
|
14
CONMED
CNMD
$1.68B
| $24.9M | 3.23% | 260,000 +99,470 | +62% | +$9.53M |
|
15
Cigna
CI
$80.3B
| $21.1M | 2.73% | +80,000 | New | +$21.1M |
|
16
Inspire Medical Systems
INSP
$2.77B
| $20.8M | 2.7% | +113,938 | New | +$20.8M |
|
17
Establishment Labs
ESTA
$1.2B
| $17.7M | 2.29% | +325,008 | New | +$17.7M |
|
18
908 Devices
MASS
$226M
| $17.5M | 2.27% | 850,000 +136,895 | +19% | +$2.82M |
|
|
HZNP
19
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $12M | 1.55% | 150,000 -353,744 | -70% | -$28.2M |
|
|
OHPAU
20
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $9.81M | 1.27% | 999,513 | – | – |
|
21
Surgery Partners
SGRY
$2.91B
| $7.76M | 1.01% | 268,176 -131,824 | -33% | -$3.81M |
|
22
Karyopharm Therapeutics
KPTI
$61.7M
| $4.96M | 0.64% | 1,100,000 -900,000 | -45% | -$4.06M |
|
|
SLGC
23
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $4.52M | 0.59% | 1,000,000 -770,000 | -44% | -$3.48M |
|
24
Stereotaxis
STXS
$261M
| $3.14M | 0.41% | 1,706,688 -5,224 | -0.3% | -$9.61K |
|
25
Align Technology
ALGN
$10.3B
| – | – | -50,000 | Closed | -$21.8M |
|